➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Moodys
McKesson
McKinsey
Mallinckrodt
Merck

Last Updated: March 1, 2021

DrugPatentWatch Database Preview

ADAPALENE AND BENZOYL PEROXIDE Drug Profile

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

When do Adapalene And Benzoyl Peroxide patents expire, and when can generic versions of Adapalene And Benzoyl Peroxide launch?

Adapalene And Benzoyl Peroxide is a drug marketed by Actavis Mid Atlantic, Glenmark Pharms Ltd, Perrigo Uk Finco, Taro, and Tolmar. and is included in six NDAs.

The generic ingredient in ADAPALENE AND BENZOYL PEROXIDE is adapalene; benzoyl peroxide. There are twelve drug master file entries for this compound. Six suppliers are listed for this compound. Additional details are available on the adapalene; benzoyl peroxide profile page.

Summary for ADAPALENE AND BENZOYL PEROXIDE
Drug patent expirations by year for ADAPALENE AND BENZOYL PEROXIDE
Recent Clinical Trials for ADAPALENE AND BENZOYL PEROXIDE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Mahidol UniversityPhase 2
BeiersdorfPhase 2
New York University School of MedicineN/A

See all ADAPALENE AND BENZOYL PEROXIDE clinical trials

Pharmacology for ADAPALENE AND BENZOYL PEROXIDE
Drug ClassRetinoid

US Patents and Regulatory Information for ADAPALENE AND BENZOYL PEROXIDE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Actavis Mid Atlantic ADAPALENE AND BENZOYL PEROXIDE adapalene; benzoyl peroxide GEL;TOPICAL 203790-001 Sep 30, 2015 AB RX No No   Start Trial   Start Trial   Start Trial
Taro ADAPALENE AND BENZOYL PEROXIDE adapalene; benzoyl peroxide GEL;TOPICAL 206959-001 Jan 24, 2018 AB RX No No   Start Trial   Start Trial   Start Trial
Glenmark Pharms Ltd ADAPALENE AND BENZOYL PEROXIDE adapalene; benzoyl peroxide GEL;TOPICAL 208108-001 Nov 8, 2019 AB RX No No   Start Trial   Start Trial   Start Trial
Perrigo Uk Finco ADAPALENE AND BENZOYL PEROXIDE adapalene; benzoyl peroxide GEL;TOPICAL 205033-001 Jan 23, 2018 AB RX No No   Start Trial   Start Trial   Start Trial
Tolmar ADAPALENE AND BENZOYL PEROXIDE adapalene; benzoyl peroxide GEL;TOPICAL 206164-001 May 23, 2018 AB RX No No   Start Trial   Start Trial   Start Trial
Taro ADAPALENE AND BENZOYL PEROXIDE adapalene; benzoyl peroxide GEL;TOPICAL 209148-001 Oct 17, 2018 DISCN No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKinsey
Merck
Colorcon
Baxter
Express Scripts
McKesson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.